FDA’s Globalization Strategy Needs To Be More Aggressive, Sen. Brown Suggests
This article was originally published in The Pink Sheet Daily
The Ohio Democrat says the agency has to come up with a more creative way to deal with globalization problems than ask for additional funding to put more inspectors in China.
You may also be interested in...
Compounding Hearings Are First Step In Creating Active Legislative Ingredients
Congress will explore causes and potential policy solutions to the meningitis outbreak at the New England Compounding Center in back-to-back hearings, but any legislation increasing FDA regulatory authority faces a long road.
How Do You Solve A Problem Like Sequestration?
FDA and advocates wait for OMB to clarify how the estimated 7.8% budget cut should be implemented, if it is enacted. Former agency officials say it could lead to hiring freezes and program delays.
Increased FDA China Inspections Backed By House Panel, While Purse Strings Pulled Still Tighter
Funds for the Reagan-Udall Foundation must come from the FDA commissioner’s office account, under successful amendment from Rep. DeLauro.